Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Gilead Sciences, Inc. (GILD) had Revenue of $7.80B for the most recently reported fiscal quarter, ending 2026-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2026-06-30

Income Statement Financials
Revenue	$7.80B
Net Income	$-10.50B
Cost of Goods Sold	$1.58B
Gross Profit	$6.22B
Operating Expenses	$18.20B
Operating Income	$-10.39B
Non-Operating Income/Expense	$140.00M
Pre-Tax Income	$-10.25B
Normalized Pre-Tax Income	$-10.25B
Income after Taxes	$-10.50B
Income from Continuous Operations	$-10.50B
Consolidated Net Income/Loss	$-10.50B
Normalized Income after Taxes	$-10.50B
EBIT	$-10.39B
EBITDA	$-9.70B
Weighted-Average Shares Outstanding (Basic)	1.24B
Weighted-Average Shares Outstanding (Diluted)	1.24B
Earnings per Share (EPS) (Basic)	$-8.45
Earnings per Share (EPS) (Diluted)	$-8.45
Balance Sheet Financials
Current Assets	$13.95B
Property, Plant, and Equipment	$5.83B
Long-Term Assets	$35.42B
Total Assets	$49.36B
Current Liabilities	$11.02B
Long-Term Debt	$23.83B
Long-Term Liabilities	$26.60B
Total Liabilities	$37.62B
Common Equity	$11.74B
Tangible Shareholders Equity	$-10.60B
Shareholders Equity	$11.74B
Common Shares Outstanding	1.24B
Cash Flow Statement Financials
Cash Flow from Operating Activities	$6.12B
Cash Flow from Investing Activities	$-8.58B
Cash Flow from Financial Activities	$-1.90B
Beginning Cash	$7.56B
End Cash	$3.18B
Increase/Decrease in Cash	$-4.38B
Stock-Based Compensation	$449.00M
Common Stock Dividends Paid	$-2.07B
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.27
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.67
Debt to Equity Ratio	2.23
Gross Margin	79.76%
Operating Margin	-133.21%
EBIT Margin	-133.21%
EBITDA Margin	--
Pre-Tax Profit Margin	-131.41%
Profit Margin	-134.51%
Free Cash Flow	$5.86B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.16
Inventory Turnover	0.81
Receiveable Turnover	1.54
Days Sales in Receivables	58.30
Return on Equity	-89.37%
Return on Tangible Equity	99.00%
Return on Assets	-21.26%
Return on Investments	-29.50%
Book Value Per Share	$9.46
Free Cash Flow per Share	$4.71
Operating Cash Flow per Share	$4.92

Data from Zacks Investment Research, Inc.